These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35904939)

  • 1. RhoA as a Signaling Hub Controlling Glucagon Secretion From Pancreatic α-Cells.
    Ng XW; Chung YH; Asadi F; Kong C; Ustione A; Piston DW
    Diabetes; 2022 Nov; 71(11):2384-2394. PubMed ID: 35904939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EphA4 Receptor Forward Signaling Inhibits Glucagon Secretion From α-Cells.
    Hutchens T; Piston DW
    Diabetes; 2015 Nov; 64(11):3839-51. PubMed ID: 26251403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of islet glucagon secretion: Beyond calcium.
    Hughes JW; Ustione A; Lavagnino Z; Piston DW
    Diabetes Obes Metab; 2018 Sep; 20 Suppl 2(Suppl 2):127-136. PubMed ID: 30230183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphA-Ephrin-A-mediated beta cell communication regulates insulin secretion from pancreatic islets.
    Konstantinova I; Nikolova G; Ohara-Imaizumi M; Meda P; Kucera T; Zarbalis K; Wurst W; Nagamatsu S; Lammert E
    Cell; 2007 Apr; 129(2):359-70. PubMed ID: 17448994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reestablishment of Glucose Inhibition of Glucagon Secretion in Small Pseudoislets.
    Reissaus CA; Piston DW
    Diabetes; 2017 Apr; 66(4):960-969. PubMed ID: 28130310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose suppression of glucagon secretion: metabolic and calcium responses from alpha-cells in intact mouse pancreatic islets.
    Le Marchand SJ; Piston DW
    J Biol Chem; 2010 May; 285(19):14389-98. PubMed ID: 20231269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
    Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
    Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon secretion from pancreatic α-cells.
    Briant L; Salehi A; Vergari E; Zhang Q; Rorsman P
    Ups J Med Sci; 2016 May; 121(2):113-9. PubMed ID: 27044683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes.
    Campbell SA; Golec DP; Hubert M; Johnson J; Salamon N; Barr A; MacDonald PE; Philippaert K; Light PE
    Mol Metab; 2020 Sep; 39():101014. PubMed ID: 32413586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes.
    Nigi L; Brusco N; Grieco GE; Licata G; Krogvold L; Marselli L; Gysemans C; Overbergh L; Marchetti P; Mathieu C; Dahl Jørgensen K; Sebastiani G; Dotta F
    Front Endocrinol (Lausanne); 2020; 11():630. PubMed ID: 33042009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the malate-aspartate shuttle in mouse pancreatic islets abolishes glucagon secretion without affecting insulin secretion.
    Stamenkovic JA; Andersson LE; Adriaenssens AE; Bagge A; Sharoyko VV; Gribble F; Reimann F; Wollheim CB; Mulder H; Spégel P
    Biochem J; 2015 May; 468(1):49-63. PubMed ID: 25731850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Submembrane ATP and Ca2+ kinetics in α-cells: unexpected signaling for glucagon secretion.
    Li J; Yu Q; Ahooghalandari P; Gribble FM; Reimann F; Tengholm A; Gylfe E
    FASEB J; 2015 Aug; 29(8):3379-88. PubMed ID: 25911612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human pancreatic capillaries and nerve fibers persist in type 1 diabetes despite beta cell loss.
    Richardson TM; Saunders DC; Haliyur R; Shrestha S; Cartailler JP; Reinert RB; Petronglo J; Bottino R; Aramandla R; Bradley AM; Jenkins R; Phillips S; Kang H; ; Caicedo A; Powers AC; Brissova M
    Am J Physiol Endocrinol Metab; 2023 Mar; 324(3):E251-E267. PubMed ID: 36696598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose controls glucagon secretion by directly modulating cAMP in alpha cells.
    Yu Q; Shuai H; Ahooghalandari P; Gylfe E; Tengholm A
    Diabetologia; 2019 Jul; 62(7):1212-1224. PubMed ID: 30953108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose inhibits glucagon secretion by decreasing [Ca
    Singh B; Khattab F; Gilon P
    Mol Metab; 2022 Jul; 61():101495. PubMed ID: 35421610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule glucagon release inhibitors with activity in human islets.
    Kalwat MA; Rodrigues-Dos-Santos K; Binns DD; Wei S; Zhou A; Evans MR; Posner BA; Roth MG; Cobb MH
    Front Endocrinol (Lausanne); 2023; 14():1114799. PubMed ID: 37152965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic α-cells - The unsung heroes in islet function.
    Wendt A; Eliasson L
    Semin Cell Dev Biol; 2020 Jul; 103():41-50. PubMed ID: 31983511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paracrine control of α-cell glucagon exocytosis is compromised in human type-2 diabetes.
    Omar-Hmeadi M; Lund PE; Gandasi NR; Tengholm A; Barg S
    Nat Commun; 2020 Apr; 11(1):1896. PubMed ID: 32312960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha cell dysfunction in type 1 diabetes.
    Yosten GLC
    Peptides; 2018 Feb; 100():54-60. PubMed ID: 29412832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. γ-Hydroxybutyrate does not mediate glucose inhibition of glucagon secretion.
    Yu Q; Lai BK; Ahooghalandari P; Helander A; Gylfe E; Gilon P; Tengholm A
    J Biol Chem; 2020 Apr; 295(16):5419-5426. PubMed ID: 32156704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.